Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

COSMOS Pharmaceutical (3349.T)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2021-01-251625017500Neutral
2022-03-251573016500Neutral
2022-08-101460015500Neutral
2023-02-081296014000Neutral
2023-09-2015710-No Rating
2023-10-301509016470Neutral
2023-12-081669017140Neutral
2024-01-131582016830Neutral
2024-04-131404015440Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.